Company Data

REGENXBIO Inc.

Ticker
RGNX
Current Price
$8.68 -4.19%
Market Cap
$435.4M
Price Target
Refer to Report
Volume
356.7K
52wk Range
$5.035 - $15.36
Advanced Market Data

Overview

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno-associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa).

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy